B-cell activating factor (BAFF), also known as B-lymphocyte stimulator (BLyS), is a pivotal protein in the B-cell survival and maturation pathway. It is a member of the tumor necrosis factor (TNF) ligand family and plays an essential role in the proliferation and differentiation of B cells. BAFF is primarily produced by myeloid cells, but its expression can also be found in a wide range of other cells within the immune system. The regulation of BAFF expression is complex, involving various signaling pathways and transcription factors that respond to diverse environmental cues and internal cellular conditions. The mechanisms behind BAFF upregulation involve multiple layers of control, from transcriptional activation to post-translational modifications.
Chemical compounds have been identified that can induce the expression of BAFF, pointing towards intricate interactions between these molecules and the immune system's regulatory networks. For instance, lipopolysaccharide (LPS), a component of the outer membrane of Gram-negative bacteria, is known to stimulate immune responses that include the upregulation of BAFF expression. This upregulation is achieved through the activation of toll-like receptor 4 (TLR4), setting off a signaling cascade that leads to the activation of nuclear factor-kappa B (NF-κB), a transcription factor that directly enhances BAFF gene transcription. Similarly, small molecule compounds like phorbol 12-myristate 13-acetate (PMA) activate protein kinase C (PKC), which in turn can stimulate transcription factors such as activator protein 1 (AP-1) to bind to the BAFF gene promoter and increase its expression. These examples demonstrate the profound complexity and specificity with which chemical molecules can interface with cellular signaling pathways to modulate the expression of key immunological proteins such as BAFF.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lipopolysaccharide, E. coli O55:B5 | 93572-42-0 | sc-221855 sc-221855A sc-221855B sc-221855C | 10 mg 25 mg 100 mg 500 mg | $98.00 $171.00 $425.00 $1560.00 | 12 | |
LPS triggers an immune response by activating toll-like receptor 4 (TLR4), which can initiate a signaling cascade culminating in NF-κB activation. NF-κB is a transcription factor that directly upregulates BAFF gene transcription. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA, as an activator of protein kinase C (PKC), initiates a series of intracellular events that lead to the activation of transcription factors, such as AP-1, which can directly bind to the BAFF gene promoter and stimulate its expression. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
β-Estradiol has been shown to upsurge BAFF expression in certain immune cells by engaging estrogen receptors, which can activate transcription factors involved in BAFF gene transcription. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
Cholecalciferol, via its hormonal action, can stimulate the expression of BAFF by engaging the vitamin D receptor (VDR), which can then interact with promoter regions of the BAFF gene to initiate transcription. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid increases the transcription of BAFF by activating retinoic acid receptors (RARs) that bind to retinoic acid response elements (RARE) in the BAFF gene promoter region. | ||||||
Imiquimod | 99011-02-6 | sc-200385 sc-200385A | 100 mg 500 mg | $67.00 $284.00 | 6 | |
Imiquimod, as a TLR7 agonist, can provoke an innate immune response leading to the secretion of pro-inflammatory cytokines and the subsequent transcriptional increase of BAFF within immune cells. | ||||||